3Miller M, Cosgrove B, Havas S. Update on the role of triglycerides as a risk factor for coronary heart disease[J].Curr Atheroscler Rep, 2002, 4(6) :414 - 418.
4Instull W Jr, Toth P, Mullican W, et al. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial[ J ]. Mayo Clin Proc, 2001, 76(10) :971 - 982.
5Weston C. The place of ezetimibe in clinical practice[J].Hosp Med, 2003, 64(8) :473 -478.
6Kerzner B, Corbelli J, Sharp S, et al. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia[J]. Am J Cardiol, 2003, 91 (4):418 -424.
7Stein EA. An investigative look: selective cholesterol absorption inhibitors - embarking on a new standard of care[J]. Am L Manag Care, 2002, 8(2 Suppl):S36 - S39.
8Olsson AG, Istad H, Luurila O, et al. Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia[ J]. Am Heart J, 2002,144(6): 1044 - 1051.
9Martin PD, Mitchell PD, Schneck DW. Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers[ J]. Br J Clin Pharmacol, 2002,54(5) :472 - 477.
10Saito Y, Yamada N, Teramoto T, et al. A randomized,double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia[ J ]. Atherosclerosis, 2002, 162 (2):373 - 379.
9Jux U., Baginski R.M., Arnold H. - G., et al. Detection of pharmaceutical contaminations of river, pond, and tap water from Cologne (Germany) and surroundings [J]. International Journal of Hygiene and Environmental Health, 2002, 205(5): 393- 398.
10Reddersen K., Heberer T. , Dunnbier U.. Identification and significance of phenazone drugs and their metabolites in ground- and drinking water[J]. Chemosphere, 2002, 49(6) : 539 - 544.
